GSK Consumer Healthcare Strengthens Commitment to Pharmacists with 3-Year Pharmacist Support Program, Helping Global Pharmaceutical Teams Play a Critical Role in Improving Public Health in the Age of Self-Care
Posted: October 26, 2021 at 4:00 a.m. EDT|Update: 47 minutes ago
LONDON, October 26, 2021 / PRNewswire / – GSK Consumer Healthcare Today Unveils Three-Year Program to Support the Pharmacy Profession with Additional Practical Resources, Mental Health Provisions, and Policy Change Proposals in New Report Alongside pharmacists in the age of personal care.
The new report summarizes the findings of a roundtable hosted by GSK Consumer Healthcare in collaboration with the International Pharmaceutical Federation (FIP) earlier this year, which brought together the pharmaceutical community, policy experts and industry leaders to discuss the essential role of pharmacy in the era of self-care following the COVID-19 pandemic.
“We have seen that COVID-19 has a significant impact on consumers’ understanding of self-care, leading to an increased focus on everyday wellness and healthcare. During this time, pharmacies have played a vital role in providing care and advice to their patients – especially with many other healthcare facilities closed. Our research shows that more than half of Europeans plan to see their pharmacist more often than before the pandemic. Yet in general, pharmacists remain underutilized, despite being the most widely distributed health resource in the world. Europe,” noted Tess player, Global Head of Expert at GSK Consumer Healthcare.
The report identifies six obstacles faced by the global pharmaceutical community that may prevent it from fulfilling its essential role. They are: the workload; remuneration; limited education on disease prevention; misperceptions of the public about the expertise of pharmacists; the challenges of integration into the wider health system; and support to identify and address low levels of health literacy among health care consumers.
To tackle these issues, GSK Consumer Healthcare unveils a three-year engagement program advocating for pharmaceutical policy and regulatory change, and offering a range of tailored support, training and tools to consumers. pharmacists to help them overcome the obstacles identified during the roundtable.
- Year 1 (2021-22): The focus will be on providing mental health and wellness support to pharmacists and pharmacy teams. This will also include the development of behavior change tools and guidance for pharmacists in self-care conversations.
- Year 2 (2022-2023): Emphasis will be placed on helping pharmacists to manage their workload and their well-being through the development of information and diagnostic tools for patients. Year 2 will also consist of helping pharmacists identify and support health literacy challenges through a health literacy assessment tool.
- Year 3 (2023-2024): Emphasis will be placed on continuing to improve public awareness of the role of pharmacists in self-care among health care consumers. This will include working with pharmacists to develop resources that improve health literacy, including public awareness initiatives and community health monitoring.
GSK Consumer Healthcare’s commitment will be underpinned by an ongoing advocacy program to support policy and regulatory change, aligned with the recommendations of the roundtable, and designed to address each of the six barriers faced by the global pharmaceutical community.
“We are proud partners of pharmacists around the world and are committed to supporting the global pharmaceutical community to fulfill its essential role in strengthening public health literacy and the delivery of specialized care. Our three-year plan is just the start; we have spent years working with experts to better understand the obstacles the pharmaceutical community faces and how we can empower them to realize their full potential ”, Tess player continued.
The program is part of the company’s long-standing commitment to supporting the pharmaceutical community. In September 2020, GSK Consumer Healthcare has published a Declaration of Intent on the vital role of pharmacists in the future success of health systems around the world.
“The COVID-19 pandemic has accentuated the crucial role pharmacists play in consumers’ self-care routines. Self-care involves a variety of actions that patients take to manage their health. Pharmacists play an important role in guiding patients’ self-care behaviors. assessment and effective communication are essential to meaningful self-care counseling. Pharmacists can act as advocates who empower patients and help them make healthy lifestyle choices, recommend appropriate over-the-counter medications, and educate consumers on when to see a doctor, ” said Lars-Åke Söderlund, vice-president of the International Pharmaceutical Federation, FIP.
“As the global healthcare system continues to evolve, self-care is expected to play an increasing role in the treatment of certain minor ailments, and pharmacists are at the forefront of these changes and can lead the ‘self-care revolution’ “Söderlund continued.
For more details on GSK Consumer Healthcare’s work in supporting the pharmaceutical industry, and to read the full report, including three-year commitments, please visit https://www.linkedin.com/showcase/gsk-healthpartner-hcp/
About GSK Consumer Healthcare
GSK Consumer Healthcare combines science and consumer knowledge to create innovative, world-class healthcare brands that consumers trust and experts recommend for oral health, pain relief, respiratory tract and The well-being. For more information please visit www.gsk.com.
The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists and maintains official relations with the World Health Organization. Through our 146 member organizations, we represent more than four million practitioners and scientists around the world. Our vision is a world where everyone has access to safe, effective, quality and affordable medicines and pharmaceutical care. www.fip.org
GSK Consumer Healthcare
+1 732 215 6564
Show original content:
SOURCE GSK Consumer Healthcare
The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.